About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 15 results:

Free
Symposium report

Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange

T Sonia Boender, Françoise Barré-Sinoussi, David Cooper, Eric Goosby, Catherine Hankins, Michiel Heidenrijk, Menno de Jong, Michel Kazatchkine, Fola Laoye, Michael Merson, Peter Reiss, Tobias F Rinke de Wit, Khama Rogo, Onno Schellekens, Constance Schultsz, Kim CE Sigaloff, John Simon, Debrework Zewdie

Antiviral Therapy 2015; 20:101-108


Case report

Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions

Sebastian Grund, Charikleia Gkioule, Tahani Termos, Nico Pfeifer, Guido Kobbe, Jens Verheyen, Ortwin Adams

Antiviral Therapy 2015; 20:97-100


Case report

Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects?

Cheng-Hsun Lu, Jia-Huei Tsai, Mu-Zon Wu, Chia-Li Yu, Song-Chou Hsieh

Antiviral Therapy 2015; 20:93-96


Case report

Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases

Mohammed Khalid, Fahad Al Rabiah, Basha Khan, Abdullah Al Mobeireek, Taimur S Butt, Eid Al Mutairy

Antiviral Therapy 2015; 20:87-91


Short communication

Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1–4

Adele L McCormick, Lawrence Wang, Ana Garcia-Diaz, Malcolm J Macartney, Daniel P Webster, Tanzina Haque

Antiviral Therapy 2015; 20:81-85


Short communication

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013

Joanne D Stekler, Jennifer McKernan, Ross Milne, Kenneth A Tapia, Kateryna Mykhalchenko, Sarah Holte, Janine Maenza, Claire E Stevens, Susan E Buskin, James I Mullins, Lisa M Frenkel, Ann C Collier

Antiviral Therapy 2015; 20:77-80


Short communication

Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia

Saran Vardhanabhuti, Babafemi Taiwo, Daniel R Kuritzkes, Joseph J Eron, Jr, Ronald J Bosch

Antiviral Therapy 2015; 20:73-76


Original article

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

Pablo Labarga, José V Fernández-Montero, Carmen de Mendoza, Pablo Barreiro, Vincent Soriano

Antiviral Therapy 2015; 20:65-72


Original article

Atazanavir exposure is effective during pregnancy regardless of tenofovir use

Angela Colbers, David Hawkins, Carmen Hidalgo-Tenorio, Marchina van der Ende, Andrea Gingelmaier, Katharina Weizsäcker, Kabamba Kabeya, Graham Taylor, Jürgen Rockstroh, John Lambert, José Moltó, Christoph Wyen, S Tariq Sadiq, Jelena Ivanovic, Carlo Giaquinto, David Burger, the PANNA network

Antiviral Therapy 2015; 20:57-64


Original article

Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor

Norio Sugaya, Yuko Sakai-Tagawa, Masahiro Bamba, Rieko Yasuhara, Masahiko Yamazaki, Chiharu Kawakami, Yoshio Yamaguchi, Yoshiaki Ide, Masataka Ichikawa, Keiko Mitamura, Yoshihiro Kawaoka

Antiviral Therapy 2015; 20:49-55


Page:
Copyright © Nucleus Global 2015. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.